Division of
Pharmacologic
Therapies
home
regulations
pharmacotherapy
co-morbidities
find treatment
patient resources
provider resources
Advanced Search
|
Help
Opioid Treatment Regulation
Accreditation
Certification
Exception Requests
Buprenorphine
Guidance to OTPs
...more
Pharmacotherapy
Buprenorphine
Methadone
Naltrexone
...more
Co-morbidities
Hepatitis
HIV/AIDS
Co-Occurring Disorders
...more
Find Treatment
Find Treatment in Your Area
Patient & Family Resources
About MAT
Support Organizations
...more
Provider Resources
SAMHSA D-ATM
(Digital Access to Medication)
Provider Training
Addiction Technology Transfer Centers
...more
About the Division of Pharmacologic Therapies (DPT)
Legislation and Regulation
Regulations
42 CFR Part 8 Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule
(PDF, 529 KB)
Legislation
The Children's Health Act of 2000: A Summary
Overview of the Children's Health Act of 2000
(Power Point presentation)
Federal Register Notices
Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Addition of Buprenorphine and Buprenorphine Combination to List of Approved Opioid Treatment Medications
, May 22, 2003
Notice of Approval of OTP Accreditation Organizations
, December 3, 2001
Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Repeal of Current Regulations and Issuance of New Regulations: Delay of Effective Date and Resultant Amendments to the Final Rule
, March 2001
*PDF formatted files require that Adobe Acrobat Reader® program.
Follow this link to download this FREE software now from Adobe.
*PPT formatted files require that Microsoft Powerpoint Viewer.
Follow this link to download this FREE software now from Microsoft.
Note to users of screen readers and other assistive technologies: Please report your problems
to us at
otp-extranet@opioid.samhsa.gov
.